application): This proposal aims to establish a new ADRC at UCI which will focus on the basic cellular and molecular mechanisms of brain aging and AD, and seek to identify mechanisms of early pathogenic change and relate these mechanisms to cognitive and behavioral functions. Building upon the existing UCI Institute for Brain Aging and Dementia and continuing commitments by UCI to further develop Alzheimer's Disease (AD) research, the new ADRC will offer an opportunity to link pioneering basic research into early cellular and molecular mechanisms of AD to clinical applications, and apply clinical insights to basic research. The new ADRC will bring several themes to AD research: first and foremost is a cutting edge basic science perspective, second, a dedicated commitment to link basic and clinical studies, and third, an infrastructure to unite the ADRC and pioneer new initiatives that exploit the latest technological advances in bioinformatics. The technological initiatives, coordinated through the Data Management and Biostatistics Subcore (Administrative Core), are directed at fostering investigator-initiated research and bridging clinical and basic research. The four ADRC Projects are directed at investigating mechanisms hypothesized to contribute to early changes in AD brain that lead or contribute to AD progression. Three focus on cellular and molecular mechanisms. While there is always some debate, many investigators recognize three candidate mechanisms associated with the pathogenesis of AD: 1) beta-amyloid accumulation, 2) Inflammatory responses, and 3) Abnormalities in calcium homeostasis. Each of the projects addresses one of these candidate mechanisms. The fourth project will use statistical approaches in contemporary cognitive sciences (multinomial processing tree models) to define deficient sub-processes underlying losses in performance, particularly in early stage subjects. As its Long-term goal, the UCI-ADRC will strive to incorporate the latest in modern neuroscience and cognitive neuroscience to elucidate the nature of circuit dysfunction-mediated behavioral changes. The proposed ADRC infrastructure will support the projects and over 30 other faculty investigators in the ADRC.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG016573-04
Application #
6631491
Study Section
Special Emphasis Panel (ZAG1-PKN-7 (J1))
Program Officer
Phelps, Creighton H
Project Start
2000-04-15
Project End
2005-03-31
Budget Start
2003-05-01
Budget End
2004-03-31
Support Year
4
Fiscal Year
2003
Total Cost
$1,373,189
Indirect Cost
Name
University of California Irvine
Department
Neurology
Type
Schools of Medicine
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Najafi, Allison R; Crapser, Joshua; Jiang, Shan et al. (2018) A limited capacity for microglial repopulation in the adult brain. Glia 66:2385-2396
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Torres, Maria D; Garcia, Octavio; Tang, Cindy et al. (2018) Dendritic spine pathology and thrombospondin-1 deficits in Down syndrome. Free Radic Biol Med 114:10-14
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Largent, Emily A; Karlawish, Jason; Grill, Joshua D (2018) Study partners: essential collaborators in discovering treatments for Alzheimer's disease. Alzheimers Res Ther 10:101
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Miranda, Andre M; Herman, Mathieu; Cheng, Rong et al. (2018) Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer's Disease. Cell Rep 23:2967-2975
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10

Showing the most recent 10 out of 518 publications